| Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, ... Cell 183 (1), 158-168. e14, 2020 | 2010 | 2020 |
| Natural killer cell immunotypes related to COVID-19 disease severity C Maucourant, I Filipovic, A Ponzetta, S Aleman, M Cornillet, L Hertwig, ... Science immunology 5 (50), eabd6832, 2020 | 440 | 2020 |
| MAIT cell activation and dynamics associated with COVID-19 disease severity T Parrot, JB Gorin, A Ponzetta, KT Maleki, T Kammann, J Emgård, ... Science immunology 5 (51), eabe1670, 2020 | 194 | 2020 |
| Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages RS Rekha, SSVJ Rao Muvva, M Wan, R Raqib, P Bergman, S Brighenti, ... Autophagy 11 (9), 1688-1699, 2015 | 190 | 2015 |
| Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial A Mily, RS Rekha, SMM Kamal, ASM Arifuzzaman, Z Rahim, L Khan, ... PloS one 10 (9), e0138340, 2015 | 181 | 2015 |
| Impaired Expression of Perforin and Granulysin in CD8+ T Cells at the Site of Infection in Human Chronic Pulmonary Tuberculosis J Andersson, A Samarina, J Fink, S Rahman, S Grundström Infection and immunity 75 (11), 5210-5222, 2007 | 150 | 2007 |
| Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity E Kvedaraite, L Hertwig, I Sinha, A Ponzetta, I Hed Myrberg, M Lourda, ... Proceedings of the National Academy of Sciences 118 (6), e2018587118, 2021 | 137 | 2021 |
| Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions S Rahman, B Gudetta, J Fink, A Granath, S Ashenafi, A Aseffa, M Derbew, ... The American journal of pathology 174 (6), 2211-2224, 2009 | 136 | 2009 |
| Bcl-3 and NFκB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells S Grundström, P Anderson, P Scheipers, A Sundstedt Journal of Biological Chemistry 279 (9), 8460-8468, 2004 | 122 | 2004 |
| Local immune responses in human tuberculosis: learning from the site of infection S Brighenti, J Andersson Journal of Infectious Diseases 205 (suppl_2), S316-S324, 2012 | 117 | 2012 |
| Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3 S Ashenafi, G Aderaye, A Bekele, M Zewdie, G Aseffa, ATN Hoang, ... Clinical immunology 151 (2), 84-99, 2014 | 106 | 2014 |
| B in TB: B cells as mediators of clinically relevant immune responses in tuberculosis M Rao, D Valentini, T Poiret, E Dodoo, S Parida, A Zumla, S Brighenti, ... Clinical Infectious Diseases 61 (suppl_3), S225-S234, 2015 | 94 | 2015 |
| Modeling Mycobacterium tuberculosis early granuloma formation in experimental human lung tissue VR Parasa, MJ Rahman, AT Ngyuen Hoang, M Svensson, S Brighenti, ... Disease models & mechanisms 7 (2), 281-288, 2014 | 87 | 2014 |
| Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+ CD25+ regulatory T cells in vivo S Grundstrom, L Cederbom, A Sundstedt, P Scheipers, F Ivars the Journal of Immunology 170 (10), 5008-5017, 2003 | 84 | 2003 |
| Vitamin D and tuberculosis: where next? S Brighenti, P Bergman, AR Martineau Journal of internal medicine 284 (2), 145-162, 2018 | 80 | 2018 |
| High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19 M Lourda, M Dzidic, L Hertwig, H Bergsten, LM Palma Medina, I Sinha, ... Proceedings of the National Academy of Sciences 118 (40), e2109123118, 2021 | 77 | 2021 |
| Innate lymphoid cell composition associates with COVID‐19 disease severity M García, E Kokkinou, A Carrasco Garcia, T Parrot, LM Palma Medina, ... Clinical & translational immunology 9 (12), e1224, 2020 | 76 | 2020 |
| Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis A Mily, S Kalsum, MG Loreti, RS Rekha, JR Muvva, M Lourda, S Brighenti J. Vis. Exp 163, e61807, 2020 | 74 | 2020 |
| Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG … S Rahman, A Rehn, J Rahman, J Andersson, M Svensson, S Brighenti Clinical immunology 156 (2), 85-97, 2015 | 64 | 2015 |
| Safety and immunogenicity of the novel H4: IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials M Norrby, T Vesikari, L Lindqvist, M Maeurer, R Ahmed, S Mahdavifar, ... Vaccine 35 (12), 1652-1661, 2017 | 62 | 2017 |
